Trinity Biotech (TRIB) Capital Expenditures (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Capital Expenditures of -$157000.0 for Q4 2024, up 37.2% year-on-year from -$114431.5 in Q1 2024, and up 37.2% on a QoQ basis from -$250000.0 in Q4 2023.
Trinity Biotech (TRIB) Capital Expenditures (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Capital Expenditures for 12 consecutive years, with -$157000.0 the latest figure, recorded in Q4 2024.
- Quarterly Capital Expenditures rose 37.2% year-over-year to -$157000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.0 million (up 13.97% YoY) and the FY2025 annual result came in at $88000.0, down 78.27% from the prior year.
- Capital Expenditures improved to -$157000.0 in Q4 2024 per TRIB's latest filing, from -$250000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for TRIB reached as high as -$143.0 in Q2 2022 and fell as low as -$570000.0 in Q4 2021.
- A 4-year average of -$237691.5 and a median of -$203500.0 in 2023 frame the typical range for Capital Expenditures.
- The largest YoY upside for Capital Expenditures was 63.24% in 2022 against a maximum downside of 16.67% in 2022.
- Year by year, Capital Expenditures stood at -$570000.0 in 2021, then climbed by 16.67% to -$475000.0 in 2022, then jumped by 47.37% to -$250000.0 in 2023, then jumped by 37.2% to -$157000.0 in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$157000.0, -$250000.0, and -$128000.0 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 64.90 Mn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 178.00 Mn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 76.60 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -85.46 Mn |
| 10 | Trinity Biotech | 110.59 Mn | 105.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -157,000.00 |
| Dec 31, 2024 | -157,000.00 |
| Dec 31, 2023 | -250,000.00 |
| Dec 31, 2023 | -250,000.00 |
| Sep 30, 2023 | -128,000.00 |
| Sep 30, 2023 | -128,000.00 |
| Dec 31, 2022 | -475,000.00 |
| Dec 31, 2022 | -475,000.00 |
| Sep 30, 2022 | -321,000.00 |
| Sep 30, 2022 | -321,000.00 |
| Jun 30, 2022 | -143.00 |
| Jun 30, 2022 | -143.00 |
| Dec 31, 2021 | -570,000.00 |
| Dec 31, 2021 | -570,000.00 |
| Jun 30, 2021 | -389.00 |
| Jun 30, 2021 | -389.00 |
| Dec 31, 2016 | 2.81 Mn |
| Dec 31, 2016 | 2.81 Mn |
| Dec 31, 2015 | 2.83 Mn |
| Dec 31, 2015 | 2.83 Mn |